Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marre, M.
Right arrow Articles by Alhenc-Gelas, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marre, M.
Right arrow Articles by Alhenc-Gelas, F.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 43, Issue 3 384-388, Copyright © 1994 by American Diabetes Association


ARTICLES

Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications

M Marre, P Bernadet, Y Gallois, F Savagner, TT Guyene, M Hallab, F Cambien, P Passa and F Alhenc-Gelas
Medical Department B, University Hospital, Angers, France.

Insulin-dependent diabetes mellitus (IDDM), cardiovascular morbidity, and vital prognosis are linked to diabetic nephropathy, which is probably determined by renal hemodynamic abnormalities and by a genetic predisposition. Angiotensin I converting enzyme (ACE) regulates systemic and renal circulations through angiotensin II formation and kinins metabolism. Plasma and cellular ACE levels are genetically determined; an insertion/deletion polymorphism of the ACE gene is strongly associated with ACE levels, subjects homozygote for insertion (genotype II) having the lowest plasma values. We studied the relationship between the ACE gene polymorphism or plasma levels and microcirculatory disorders of IDDM through two independent studies: one involved 57 subjects with or without diabetic retinopathy, and the other compared 62 IDDM subjects with diabetic nephropathy to 62 diabetic control subjects with the same characteristics (including retinopathy severity) but with normal kidney function. The ACE genotype distribution was not different in diabetic subjects with or without retinopathy and in a healthy population. Conversely, an imbalance of ACE genotype distribution, with a low proportion of II subjects, was observed in IDDM subjects with diabetic nephropathy compared with their control subjects (P = 0.006). Plasma ACE levels were mildly elevated in all diabetic groups, independently of retinopathy, but they were higher in subjects with nephropathy than in those without nephropathy (P = 0.0022). The II genotype of ACE gene is a marker for reduced risk for diabetic nephropathy.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
Y. Qian, E. Feldman, S. Pennathur, M. Kretzler, and F. C. Brosius III
From Fibrosis to Sclerosis: Mechanisms of Glomerulosclerosis in Diabetic Nephropathy
Diabetes, June 1, 2008; 57(6): 1439 - 1445.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. Tarnow, P.-H. Groop, S. Hadjadj, G. Kazeem, F. Cambien, M. Marre, C. Forsblom, H.-H. Parving, D. Tregouet, A. Thevard, et al.
European rational approach for the genetics of diabetic complications EURAGEDIC: patient populations and strategy
Nephrol. Dial. Transplant., August 17, 2007; (2007) gfm501v1.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Hadjadj, L. Tarnow, C. Forsblom, G. Kazeem, M. Marre, P.-H. Groop, H.-H. Parving, F. Cambien, D. A. Tregouet, I. G. Gut, et al.
Association between Angiotensin-Converting Enzyme Gene Polymorphisms and Diabetic Nephropathy: Case-Control, Haplotype, and Family-Based Study in Three European Populations
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1284 - 1291.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. L. Stone, M. E. Craig, A. K. Chan, J. W. Lee, C. F. Verge, and K. C. Donaghue
Natural History and Risk Factors for Microalbuminuria in Adolescents With Type 1 Diabetes: A longitudinal study.
Diabetes Care, September 1, 2006; 29(9): 2072 - 2077.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. P.K. Ng, G. Placha, S. Choo, K.-s. Chia, J. H. Warram, and A. S. Krolewski
A Disease Haplotype for Advanced Nephropathy in Type 2 Diabetes at the ACE Locus
Diabetes, September 1, 2006; 55(9): 2660 - 2663.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. Weekers, B. Bouhanick, S. Hadjadj, Y. Gallois, R. Roussel, F. Pean, A. Ankotche, G. Chatellier, F. Alhenc-Gelas, P. J. Lefebvre, et al.
Modulation of the Renal Response to ACE Inhibition by ACE Insertion/Deletion Polymorphism During Hyperglycemia in Normotensive, Normoalbuminuric Type 1 Diabetic Patients
Diabetes, October 1, 2005; 54(10): 2961 - 2967.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. P. Boright, A. D. Paterson, L. Mirea, S. B. Bull, A. Mowjoodi, S. W. Scherer, B. Zinman, and and the DCCT/EDIC Research Group
Genetic Variation at the ACE Gene Is Associated With Persistent Microalbuminuria and Severe Nephropathy in Type 1 Diabetes: The DCCT/EDIC Genetics Study
Diabetes, April 1, 2005; 54(4): 1238 - 1244.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kakoki, N. Takahashi, J. C. Jennette, and O. Smithies
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor
PNAS, September 7, 2004; 101(36): 13302 - 13305.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
I Narita, S Goto, N Saito, J Song, K Omori, D Kondo, M Sakatsume, and F Gejyo
Renoprotective efficacy of renin-angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism
J. Med. Genet., December 1, 2003; 40(12): e130 - 130.
[Full Text]


Home page
EndocrinologyHome page
N. Takahashi, J. R. Hagaman, H.-S. Kim, and O. Smithies
Minireview: Computer Simulations of Blood Pressure Regulation by the Renin-Angiotensin System
Endocrinology, June 1, 2003; 144(6): 2184 - 2190.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Andersen, L. Tarnow, F. Cambien, P. Rossing, T. R. Juhl, J. Deinum, and H.-H. Parving
Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype?
Diabetes Care, May 1, 2003; 26(5): 1501 - 1506.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Taniwaki, E. Ishimura, T. Kawagishi, N. Matsumoto, M. Hosoi, M. Emoto, T. Shoji, S. Shoji, T. Nakatani, M. Inaba, et al.
Intrarenal Hemodynamic Changes After Captopril Test in Patients With Type 2 Diabetes: A duplex Doppler sonography study
Diabetes Care, January 1, 2003; 26(1): 132 - 137.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
W. X. Liao and A. C. Roy
Lack of association between polymorphisms in the testis-specific angiotensin converting enzyme gene and male infertility in an Asian population
Mol. Hum. Reprod., March 1, 2002; 8(3): 299 - 303.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
J. P Garg and G. L Bakris
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
Vascular Medicine, February 1, 2002; 7(1): 35 - 43.
[Abstract] [PDF]


Home page
DiabetesHome page
A. Solini, M. Dalla Vestra, A. Saller, R. Nosadini, G. Crepaldi, and P. Fioretto
The Angiotensin-Converting Enzyme DD Genotype Is Associated With Glomerulopathy Lesions in Type 2 Diabetes
Diabetes, January 1, 2002; 51(1): 251 - 255.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Huang, Y. Gallois, N. Bouby, P. Bruneval, D. Heudes, M.-F. Belair, J. H. Krege, P. Meneton, M. Marre, O. Smithies, et al.
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
PNAS, October 25, 2001; (2001) 231476798.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Taniwaki, E. Ishimura, N. Matsumoto, M. Emoto, M. Inaba, and Y. Nishizawa
Relations Between ACE Gene and ecNOS Gene Polymorphisms and Resistive Index in Type 2 Diabetic Patients With Nephropathy
Diabetes Care, September 1, 2001; 24(9): 1653 - 1660.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. B. Harrap and S. Petrou
Utility of genetic approaches to common cardiovascular diseases
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H1 - H6.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Sanada, Y. Higashi, K. Nakagawa, S. Sasaki, I. Kodama, M. Tsuda, N. Nagai, and K. Ohama
Relationship between the angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women
J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1529 - 1535.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. HADJADJ, R. BELLOUM, B. BOUHANICK, Y. GALLOIS, G. GUILLOTEAU, G. CHATELLIER, F. ALHENC-GELAS, and M. MARRE
Prognostic Value of Angiotensin-I Converting Enzyme I/D Polymorphism for Nephropathy in Type 1 Diabetes Mellitus: A Prospective Study
J. Am. Soc. Nephrol., March 1, 2001; 12(3): 541 - 549.
[Abstract] [Full Text]


Home page
HypertensionHome page
G. P. Rossi, S. Taddei, A. Virdis, L. Ghiadoni, G. Albertin, S. Favilla, I. Sudano, A. C. Pessina, and A. Salvetti
Exclusion of the ACE D/I Gene Polymorphism as a Determinant of Endothelial Dysfunction
Hypertension, February 1, 2001; 37(2): 293 - 300.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
D. Crisan and J. Carr
Angiotensin I-Converting Enzyme: Genotype and Disease Associations
J. Mol. Diagn., August 1, 2000; 2(3): 105 - 115.
[Full Text]


Home page
CirculationHome page
W. Koch, A. Kastrati, J. Mehilli, C. Bottiger, N. von Beckerath, and A. Schomig
Insertion/Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene Is Not Associated With Restenosis After Coronary Stent Placement
Circulation, July 11, 2000; 102(2): 197 - 202.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M.-C. Hsieh, S.-R. Lin, T.-J. Hsieh, C.-H. Hsu, H.-C. Chen, S.-J. Shin, and J.-H. Tsai
Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan
Nephrol. Dial. Transplant., July 1, 2000; 15(7): 1008 - 1013.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Higaki, S. Baba, T. Katsuya, N. Sato, K. Ishikawa, T. Mannami, J. Ogata, and T. Ogihara
Deletion Allele of Angiotensin-Converting Enzyme Gene Increases Risk of Essential Hypertension in Japanese Men : The Suita Study
Circulation, May 2, 2000; 101(17): 2060 - 2065.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
T. OGIHARA, T. KATSUYA, and J. HIGAKI
Genetic Analysis of Essential Hypertension in Japanese Populations
Ann. N.Y. Acad. Sci., May 1, 2000; 902(1): 8 - 16.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Lovestone
Diabetes and dementia
Neurology, December 1, 1999; 53(9): 1907 - 1907.
[Full Text]


Home page
J. Am. Soc. Nephrol.Home page
M. NANNIPIERI, G. PENNO, L. PUCCI, H. COLHOUN, C. MOTTI, A. BERTACCA, L. RIZZO, L. DE GIORGIO, G. ZERBINI, R. MANGILI, et al.
Pronatriodilatin Gene Polymorphisms, Microvascular Permeability, and Diabetic Nephropathy in Type 1 Diabetes Mellitus
J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1530 - 1541.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
O. Costerousse, J. Allegrini, J.-P. Clozel, J. Ménard, and F. Alhenc-Gelas
Angiotensin I-Converting Enzyme Inhibition but Not Angiotensin II Suppression Alters Angiotensin I-Converting Enzyme Gene Expression in Vessels and Epithelia
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1180 - 1187.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. S. Yudkin, C. Andres, V. Mohamed-Ali, M. Gould, A. Panahloo, A. P. Haines, S. Humphries, and P. Talmud
The Angiotensin-Converting Enzyme Gene and the Angiotensin II Type I Receptor Gene as Candidate Genes for Microalbuminuria : A Study in Nondiabetic and Non–Insulin-Dependent Diabetic Subjects
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2188 - 2191.
[Abstract] [Full Text]


Home page
BMJHome page
M. Marre, G. Chatellier, and F. Alhenc-Gelas
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy
BMJ, December 14, 1996; 313(7071): 1554c - 1555.
[Full Text]


Home page
CirculationHome page
M. Hosoi, Y. Nishizawa, K. Kogawa, T. Kawagishi, T. Konishi, K. Maekawa, M. Emoto, S. Fukumoto, A. Shioi, T. Shoji, et al.
Angiotensin-Converting Enzyme Gene Polymorphism Is Associated With Carotid Arterial Wall Thickness in Non–Insulin-Dependent Diabetic Patients
Circulation, August 15, 1996; 94(4): 704 - 707.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. Doria, T. Onuma, G. Gearin, M. B. S. Freire, J. H. Warram, and A. S. Krolewski
Angiotensinogen Polymorphism M235T, Hypertension, and Nephropathy in Insulin-Dependent Diabetes
Hypertension, May 1, 1996; 27(5): 1134 - 1139.
[Abstract] [Full Text]


Home page
CirculationHome page
M.-L. Lachurie, M. Azizi, T.-T. Guyene, F. Alhenc-Gelas, and J. Menard
Angiotensin-Converting Enzyme Gene Polymorphism Has No Influence on the Circulating Renin-Angiotensin-Aldosterone System or Blood Pressure in Normotensive Subjects
Circulation, June 15, 1995; 91(12): 2933 - 2942.
[Abstract] [Full Text]


Home page
BMJHome page
A. Breckenridge
Recent Advances: Clinical pharmacology and therapeutics
BMJ, February 11, 1995; 310(6976): 377 - 380.
[Full Text]


Home page
BMJHome page
J K Powrie, G F Watts, J N Ingham, N A Taub, P J Talmud, and K M Shaw
Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes
BMJ, December 17, 1994; 309(6969): 1608 - 1612.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Huang, Y. Gallois, N. Bouby, P. Bruneval, D. Heudes, M.-F. Belair, J. H. Krege, P. Meneton, M. Marre, O. Smithies, et al.
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
PNAS, November 6, 2001; 98(23): 13330 - 13334.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1994 by the American Diabetes Association.